An original stem cell study provides insight into Klinefelter syndrome.

Published Date: 05 Apr 2023

Scientists have conducted a first-of-its-kind study in a collaboration between King Abdullah University of Science and Technology (KAUST), King Abdulaziz University, Jeddah (KAU), and King Abdulaziz University Hospital, Jeddah (KAUH).

Read Full News

Latest News

Analysis-Older Americans Left Out Of Costly GLP-1 Craze Expected to Flock to New Program

Millions more Americans will qualify for obesity medications at just $50 a month under a new Medicare program starting on Wednesday, bringing the highly effective drugs to...

Explainer-Who Qualifies for Medicare's New $50 Weight-loss Drug Program and What Are the Concerns?

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on Wednesday in its Medicare program for people aged 65...

Tirzepatide Weight Loss Greater in Women vs Men, Age No Link

In adults with overweight or obesity using tirzepatide for at least 12 months, women lost more weight, but age was not a predictor.

Pfizer, Innovent GLP-1 Drugs Clear China Insurance Hurdle

GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary review to be potentially included in China's basic medical ⁠insurance drug catalogue.

A Year After Keto: Fat Loss Persists, Metabolism Recovers

In women with obesity, a very low-calorie ketogenic diet followed by structured refeeding can help maintain meaningful weight loss at 1 year while allowing the body’s energy expenditure to recover.

Hybio's Generic Weight-loss Drug Set for FDA Review

The U.S. Food and Drug Administration has agreed to review ⁠Chinese generics drugmaker Hybio Pharmaceutical's two experimental generic tirzepatide GLP-1s that, if approved,...

Todays Updates

Breast Cancer Incidence Rises in Asian American Women

A cross-sectional population-based study examines trends in invasive breast cancer incidence rates in Asian American, Native Hawaiian, and Pacific Islander ethnic groups.

Todays Updates

Breast Cancer Incidence Rises in Asian American Women

A cross-sectional population-based study examines trends in invasive breast cancer incidence rates in Asian American, Native Hawaiian, and Pacific Islander ethnic groups.

Latest News

Millions more Americans will qualify for obesity medications at just $50 a month under a new Medicare program starting on Wednesday, bringing the highly effective drugs to...

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on Wednesday in its Medicare program for people aged 65...

In adults with overweight or obesity using tirzepatide for at least 12 months, women lost more weight, but age was not a predictor.

GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary review to be potentially included in China's basic medical ⁠insurance drug catalogue.

In women with obesity, a very low-calorie ketogenic diet followed by structured refeeding can help maintain meaningful weight loss at 1 year while allowing the body’s energy expenditure to recover.

The U.S. Food and Drug Administration has agreed to review ⁠Chinese generics drugmaker Hybio Pharmaceutical's two experimental generic tirzepatide GLP-1s that, if approved,...

News All Time

Imaging Predicts Therapy Failure in T2-T3 Glottic Cancers

Vertical anterior commissure involvement identified on preoperative imaging predicts poor outcomes in patients undergoing primary chemoradiotherapy for T2-T3 glottic tumours.

Bariatric Surgery Outperforms Diet for Cancer Prevention

Metabolic/bariatric surgery is linked to a lower risk for multiple cancers in patients with severe obesity than dietary counseling, a large analysis shows.

Bone Agents Underused, and Declining, in Prostate Cancer

Many patients with metastatic castration-resistant prostate cancer are not receiving bone-modifying agents, despite guideline endorsement.

Novo's Top US Exec Wants More Insurance Coverage for Weight-loss Drugs

Denmark's Novo Nordisk, the maker of weight-loss drug Wegovy, hopes insurance will cover more U.S. users of the medication and balance direct-to-consumer sales that have...

Two Studies Link GLP-1 Use to Lower Breast Cancer Risk

Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

Trump Pricing Policy Will Affect Obesity Drug Launch in Europe

Eli Lilly expects to launch its weight-loss pill in Europe and Britain in the second half of ⁠2026 or early 2027, with the drugmaker targeting the out-of-pocket telehealth market.

GLP-1 QOL Benefits Greatest for Those With Obesity Plus T2D

Patients with co-occurring obesity and T2D have more favorable QOL outcomes on GLP-1s than those with either condition alone or multiple comorbidities.

Mediterranean Diet May Reduce Postpartum Metabolic Risk

A Mediterranean-based nutritional intervention initiated at 8-12 gestational weeks is associated with a reduced risk for metabolic syndrome 6 years postpartum, a prospective follow-up study finds.

China Approval for Eli Lilly GLP-1 Pill to Come as Soon as 2026, Executive Says

Eli Lilly's orforglipron type-2 diabetes and obesity pill could launch in China as soon ⁠as later this year, an executive at the U.S. drugmaker told Reuters, as rival Novo...

Urogenital Infections Tied to SGLT2 Therapy Discontinuation

Patients with type 2 diabetes who start SGLT2 inhibitors and then develop a urinary or genital tract infection are more likely to discontinue treatment than matched patients without an infection.

Fasting and Calorie Restriction Work via Different Pathways

In adults with obesity, both intermittent fasting and calorie restriction lead to significant weight loss but act through distinct behavioral pathways.

What GLP-1s Are Teaching Us About Compulsive Behavior

As GLP-1 research moves deeper into the brain, scientists are asking whether these drugs can help explain why some urges become so hard to resist.

Protein Source Key for Weight Loss After Menopause

Postmenopausal women are often encouraged to eat more protein, but a new study finds that protein source matters, with plant-based protein outperforming animal protein for weight loss.

GLP-1s Tied to Reduced Opioid Use in Chronic Pancreatitis

Among patients with chronic pancreatitis, GLP‑1 treatment is associated with a lower likelihood of initiating long-term opioid therapy or developing opioid use disorder.

NHS Recommends First Drug to Delay Type 1 Diabetes

NICE has recommended teplizumab — the first medicine to delay type 1 diabetes onset — in what Diabetes UK calls ‘a new age of treatment.’

GLP-1 Era Demands a New Model of Obesity Care

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

Recommended News For You

The main subject is associated with suicide in the United States.

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.

Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.

Future of Lab-Developed Tests Still Taking Shape

Integrative palliative care is critical to improving mental health among pancreatic cancer patients

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

Recommended Articles For You

Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine 

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment 

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options  

Personalized Tumor Ecological Landscapes in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Promising for Monitoring and Diagnosis of AD is the finger-prick test.

2.

Advances in "next generation" photoactive cancer therapy

3.

Housing aid linked to lower medical financial hardship among US renters with cancer

4.

Preventable pediatric cancer mortality surges in areas of armed conflict, exceeding rates in non-conflict regions

5.

FDA Expands Approval of Osimertinib in Lung Cancer

1.

Precision Oncology: Tailoring Cancer Treatment for the Individual

2.

Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA

3.

Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis

4.

Understanding Mantle Cell Lymphoma Prognosis.

5.

Hematopoietic Stem Cell Fitness Biomarkers: Clinical Relevance and Emerging Paradigms

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

2.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

3.

Efficient Management of First line ALK-rearranged NSCLC - Part III

4.

Updates on the First Line Management of ALK+ NSCLC

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot